|
1
|
Beibei Y, Rong Y, Yunfei Y and Wenchao Z:
Research progress regarding surgical margins, molecular margins,
and prognosis of laryngeal carcinoma. Ear Nose Throat J
145561320903146. 2020.(Epubahead of print). View Article : Google Scholar
|
|
2
|
Olaleye O, Siddiq S, Ekrikpo U and Kazi R:
Regional differences in incidence and mortality trends in cancers
of the larynx, thyroid, oral cavity and pharynx in England and
Scotland: 1975–2002. Open Epidemiol J. 3:70–78. 2013. View Article : Google Scholar
|
|
3
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Steuer CE, El-Deiry M, Parks JR, Higgins
KA and Saba NF: An update on larynx cancer. CA Cancer J Clin.
67:31–50. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Menicagli R, Bolla G, Menicagli L and
Esseridou A: The possible role of diabetes in the etiology of
laryngeal cancer. Gulf J Oncolog. 1:44–51. 2017.PubMed/NCBI
|
|
6
|
Barradas M, Gonos ES, Zebedee Z, Kolettas
E, Petropoulou C, Delgado MD, Leon J, Hara E and Serrano M:
Identification of a candidate tumor-suppressor gene specifically
activated during Ras-induced senescence. Exp Cell Res. 273:127–137.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cheng Z, Guo J, Chen L, Luo N, Yang W and
Qu X: Overexpression of TMEM158 contributes to ovarian
carcinogenesis. J Exp Clin Cancer Res. 34:752015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mohammed Ael S, Eguchi H, Wada S, Koyama
N, Shimizu M, Otani K, Ohtaki M, Tanimoto K, Hiyama K, Gaber MS and
Nishiyama M: TMEM158 and FBLP1 as novel marker genes of cisplatin
sensitivity in non-small cell lung cancer cells. Exp Lung Res.
38:463–474. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fu Y, Yao N, Ding D, Zhang X, Liu H, Ma L,
Shi W, Zhu C and Tang L: TMEM158 promotes pancreatic cancer
aggressiveness by activation of TGFβ1 and PI3K/AKT signaling
pathway. J Cell Physiol. 235:2761–2775. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hummel R, Maurer J and Haier J: MicroRNAs
in brain tumors: A new diagnostic and therapeutic perspective? Mol
Neurobiol. 44:223–234. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rouleau S, Glouzon JS, Brumwell A,
Bisaillon M and Perreault JP: 3′ UTR G-quadruplexes regulate miRNA
binding. RNA. 23:1172–1179. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xiao X, Cao Y and Chen H: Profiling and
characterization of microRNAs responding to sodium butyrate
treatment in A549 cells. J Cell Biochem. 119:3563–3573. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liang T, Guo L and Liu C: Genome-wide
analysis of mir-548 gene family reveals evolutionary and functional
implications. J Biomed Biotechnol. 2012:6795632012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Z, Wu X, Hou X, Zhao W, Yang C, Wan W
and Chen L: MiR-548b-3p functions as a tumor suppressor in lung
cancer. Lasers Med Sci. 35:833–839. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shi Y, Qiu M, Wu Y and Hai L: MiR-548-3p
functions as an anti-oncogenic regulator in breast cancer. Biomed
Pharmacother. 75:111–116. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tashiro K, Kuroki N, Einama T, Iwasaki T,
Miyata Y, Aosasa S, Inoue Y, Takahashi Y, Ogata S, Ueno H, et al:
Prognostic significance of regional lymph node metastasis according
to station in ampullary carcinoma. J Hepatobiliary Pancreat Sci.
2020.(Epub ahead of print). View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mellis D and Caporali A: MicroRNA-based
therapeutics in cardiovascular disease: Screening and delivery to
the target. Biochem Soc Trans. 46:11–21. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qadir MI and Faheem A: MiRNA: A diagnostic
and therapeutic tool for pancreatic cancer. Crit Rev Eukaryot Gene
Expr. 27:197–204. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Iglesias D, Fernandez-Peralta AM, Nejda N,
Daimiel L, Azcoita MM, Oliart S and Gonzalez-Aguilera JJ: RIS1, a
gene with trinucleotide repeats, is a target in the mutator pathway
of colorectal carcinogenesis. Cancer Genet Cytogenet. 167:138–144.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zirn B, Samans B, Wittmann S, Pietsch T,
Leuschner I, Graf N and Gessler M: Target genes of the
WNT/beta-catenin pathway in Wilms tumors. Genes Chromosomes Cancer.
45:565–574. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu L, Zhang J, Li S, Yin L and Tai J:
Silencing of TMEM158 inhibits tumorigenesis and multidrug
resistance in colorectal cancer. Nutr Cancer. 72:662–671. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kura B, Kalocayova B, LeBaron TW, Frimmel
K, Buday J, Surovy J and Slezak J: Regulation of microRNAs by
molecular hydrogen contributes to the prevention of
radiation-induced damage in the rat myocardium. Mol Cell Biochem.
457:61–72. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Correia de Sousa M, Gjorgjieva M, Dolicka
D, Sobolewski C and Foti M: Deciphering miRNAs' Action through
miRNA Editing. Int J Mol Sci. 20:62492019. View Article : Google Scholar
|
